Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription elongation can be sufficient, but is not necessary, to advance replication timing [b-del_RNA-seq]

ABSTRACT: DNA replication timing (RT) is correlated with transcription during cell fate changes but there are many exceptions, underscoring a need for reductionist approaches. Here, we manipulated length and strength of transcription at a single site upstream of the silent, late-replicating, Pleiotrophin (Ptn) gene in mouse embryonic stem cells (mESCs). Reporter genes driven by two of four promoters elicited an RT advance while all four promoters advanced RT when driving the endogenous Ptn gene. Inducible transcription of the Ptn gene, but not the reporter gene, elicited a rapid and reversible RT advance. Deletion of the Ptn promoter and enhancer, followed by differentiation to neural precursors, eliminated transcription without attenuating the natural Ptn domain RT advance. Together with new genome-wide analyses, our results provide a solid empirical base with which to re-evaluate many decades of seemingly contradictory literature. We also identify vectors that do not disturb RT and provide a robust system to induce RT changes, permitting mechanistic studies of transcription’s role in RT and the consequences of RT changes to epigenomic remodeling.

ORGANISM(S): Mus musculus

PROVIDER: GSE312661 | GEO | 2026/02/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcription elongation can be sufficient, but is not necessary, to advance replication timing

Project description:DNA replication timing (RT) is correlated with transcription during cell fate changes but there are many exceptions, underscoring a need for reductionist approaches. Here, we manipulated length and strength of transcription at a single site upstream of the silent, late-replicating, Pleiotrophin (Ptn) gene in mouse embryonic stem cells (mESCs). Reporter genes driven by two of four promoters elicited an RT advance while all four promoters advanced RT when driving the endogenous Ptn gene. Inducible transcription of the Ptn gene, but not the reporter gene, elicited a rapid and reversible RT advance. Deletion of the Ptn promoter and enhancer, followed by differentiation to neural precursors, eliminated transcription without attenuating the natural Ptn domain RT advance. Together with new genome-wide analyses, our results provide a solid empirical base with which to re-evaluate many decades of seemingly contradictory literature. We also identify vectors that do not disturb RT and provide a robust system to induce RT changes, permitting mechanistic studies of transcription’s role in RT and the consequences of RT changes to epigenomic remodeling.

2026-02-01 | GSE310676 | GEO

Transcription elongation can be sufficient, but is not necessary, to advance replication timing [Repli-seq]

2026-02-01 | GSE310795 | GEO

Pleiotrophin drives a pro-metastatic immune niche within the breast tumor microenvironment

Project description:Here, we evaluated the effect of Pleiotrophin (PTN) depletion on tumor microenvironment. For this, we utilized a mouse monoclonal antibody against PTN, 3B10. We tested its therapeutic efficacy in 2 mouse breast cancer models, 4T1 (orthotopic, 4th mammary fat pad) and MMTV-PyMT (genetic model). Tumors from control IgG(C44) treated and 3B10 treated mice were sent for RNA sequencing to evaluate transcriptional changes. Additionally, PTN was knocked down in E0771 and E0771-LG syngeneic breast cancer lines. To evaluate transcriptional changes due to PTN depletion, shCtrl and PTN KD cells from E0771 and E0771-LG were evaluated by RNA sequencing. Overall, our results from these 4 sets of experiments show that depletion or blocking PTN results in inflammation related transcript changes suggesting function of PTN in immune regulation.

2023-02-16 | GSE200431 | GEO

High-Throughput Part Characterization and Tool Development to Advance Chloroplast Synthetic Biology

Project description:Plant synthetic biology holds promise for developing climate-resilient crop varieties particularly through advancements in engineering the chloroplast genome. However, the field faces limitations due to the scarcity of genetic tools and the long generation times of photosynthetic eukaryotes. To address these challenges, we established Chlamydomonas reinhardtii as a prototyping chassis for chloroplast synthetic biology, by significantly advancing plastome engineering tools. We developed an automation workflow that enabled the generation, handling, and analysis of 3,156 transplastomic Chlamydomonas strains and expanded the repertoire of selection markers for chloroplast transformation in Chlamydomonas to five, alongside establishing six new reporter genes. Moreover, we characterized over 140 regulatory parts, including promoters, UTRs, and intercistronic expression elements, all integrated within the Phytobrick cloning framework, for which we demonstrated a broad range of gene expression strength. Additionally, we explored library-based approaches to overcome the throughput limitations of biolistic chloroplast transformation. Finally, we demonstrated the utility of all tools by introducing a chloroplast-based synthetic photorespiration pathway. The high conservation of the chloroplast genetic system suggests that our findings in Chlamydomonas could be translated to advance chloroplast engineering in land plants and provides a prototyping platform for future crop improvements to address the challenges posed by a changing global climate.

2025-08-11 | PXD051642 | Pride

Transcription profiling of human liver biopsies from HCV associated advance disease state patients

Project description:Introduction: Mechanisms that contribute to the pathogenesis of liver damage caused by hepatitis C virus (HCV) are not fully understood. Our previous work on liver biopsies from chronic HCV patients has shown modulation of the expression of certain cell cycle proteins indicating HCV-induced modifications of cell cycle events. We therefore hypothesize that HCV infection disrupts normal regulation of cell cycle that contributes to disease progression. Objective: To identify molecular disruptions during the course of HCV-associated disease progression, using liver biopsy specimens of chronic hepatitis C patients. Methods: Liver biopsy samples classified on histological basis as early (fibrosis stage 0-1) or advanced (fibrosis stage 3-4) disease stage were studied using oligonucleotide array ( HG U133 Plus 2.0, Affymetrix GeneChipâ¢ System). For comparison, liver specimens from patients with non-viral hepatitis were also analyzed by microarray. Expression data was analyzed using Genespring (GX 7.2) and Ingenuity Pathway analysis (3.0). The differential expression of selected cell cycle genes (cyclin D2, KPNA2, HERC5 and Bcl-2) identified after microarray analysis was confirmed by quantitative real-time RT-PCR. Results: Microarray analysis revealed two-fold or greater transcriptional change in 792 genes of the total 38,500 known human genes in HCV-advance disease stage (HCV-A) as compared to HCV-early disease stage (HCV-E). Most of the genes have a defined role in immune response, extracellular matrix and cell cycle and apoptosis. Experiment Overall Design: Liver biopsy samples were collected from patients of (a) HCV-infected early disease stage (HCV-E, control 1) (b) non-HCV advance disease stage (control 2) and (c) HCV-infected advance disease stage (HCV-A) for RNA extraction. Equal amount of RNA was pooled from samples (n=4)within each group and hybridized to HG-U133 Plus 2.0 array.

2008-06-15 | E-GEOD-7741 | biostudies-arrayexpress

Rapid Response and Slow Recovery of the H3K4me3 Epigenomic Marker in the Liver After a Light-Mediated Phase Advance of the Circadian Clock

Project description:Mammalian tissues display circadian rhythms in which transcription levels rise and fall throughout a 24-hour day. These rhythms include histone modifications. Here we asked whether an advance of the light-dark cycle could alter rhythms in the liver epigenome at the H3K4me3 (trimethylation of lysine 4 on histone 3) modification, which is found at active and poised gene promoters. H3K4me3 levels were first measured at 4-time points (Zeitgeber Time [ZT] 3, 8, 15, and 20) during a normal 12L:12D light:dark cycle. Peak levels were observed during the early dark phase at ZT15, and dropped to low levels around lights-on (ZT0) between ZT20 and ZT3. A six-hour phase advance at ZT18 (new lights-on after only 6 h of darkness) led to a transient extension of peak H3K4me3 levels. Although locomotor activity re-entrained within a week after the phase advance, H3K4me3 rhythms failed to do so with peak levels remaining in the light phase at the one-week recovery time point. Eight weekly phase advances, with one-week recovery times between each phase advance, also led to disruption of the liver circadian epigenome. A model to explain these results is offered.

2018-12-01 | GSE108481 | GEO

Expression data of HCV-associated advance disease state

Project description:Introduction: Mechanisms that contribute to the pathogenesis of liver damage caused by hepatitis C virus (HCV) are not fully understood. Our previous work on liver biopsies from chronic HCV patients has shown modulation of the expression of certain cell cycle proteins indicating HCV-induced modifications of cell cycle events. We therefore hypothesize that HCV infection disrupts normal regulation of cell cycle that contributes to disease progression. Objective: To identify molecular disruptions during the course of HCV-associated disease progression, using liver biopsy specimens of chronic hepatitis C patients. Methods: Liver biopsy samples classified on histological basis as early (fibrosis stage 0-1) or advanced (fibrosis stage 3-4) disease stage were studied using oligonucleotide array ( HG U133 Plus 2.0, Affymetrix GeneChip™ System). For comparison, liver specimens from patients with non-viral hepatitis were also analyzed by microarray. Expression data was analyzed using Genespring (GX 7.2) and Ingenuity Pathway analysis (3.0). The differential expression of selected cell cycle genes (cyclin D2, KPNA2, HERC5 and Bcl-2) identified after microarray analysis was confirmed by quantitative real-time RT-PCR. Results: Microarray analysis revealed two-fold or greater transcriptional change in 792 genes of the total 38,500 known human genes in HCV-advance disease stage (HCV-A) as compared to HCV-early disease stage (HCV-E). Most of the genes have a defined role in immune response, extracellular matrix and cell cycle and apoptosis. Keywords: HCV-advance disease state

2007-11-01 | GSE7741 | GEO

Transcription elongation can be sufficient, but is not necessary, to advance replication timing

Project description:Transcription elongation can be sufficient, but is not necessary, to advance replication timing

| PRJNA1366934 | ENA

Global expression data from mouse dorsal, ventral and central suprachiasmatic nuclei sub-regions following phase advance inducing light exposure.

Project description:In mice and other mammals the suprachiasmatic nuclei (SCN) within the brain, synchronises daily rhythms in metabolism, physiology and behaviour to the Earth's local time. Whilst much is known about the SCN's time keeping mechanism, less is known about how it adjusts or resets timing to changes in local time beyond the induction of CRE regulated genes and the differential response of dorsal and ventral sub-regions of the SCN after light exposure known to advance rhythms. As transcription of several clock genes is required for maintaining daily rhythms, we assayed global transcription levels in the dorsal, ventral and central SCN following phase advance inducing light exposure to expand understanding of how the SCN adjusts to new local times.

2019-01-01 | GSE53553 | GEO

Transcription elongation can be sufficient, but is not necessary, to advance replication timing [Repli-seq]

Project description:Transcription elongation can be sufficient, but is not necessary, to advance replication timing [Repli-seq]

| PRJNA1367086 | ENA